BioSpace takes a look at the flurry of expansion activity in the life sciences industry as biopharma and diagnostic companies expand manufacturing sites.
If you are not happy with the results below please do another search
50 search results for:
In order for healthcare organizations to create healthier communities, they need insight into more than clinical patient information. They also need to see behavioral health data, which is a major indicator of risk and trends for their population. Having access to this information can feed into more effective preventative and community-based mental health services and treatments for patients.
Toronto-based biotech Deep Genomics landed $180 million in the company’s oversubscribed Series C.
Pfizer Inc. on July 28 raised the 2021 sales forecast for the company’s Covid-19 vaccine by 29 percent to $33.5 billion, and said the drugmaker believes people will need a third dose of the shot developed with German partner BioNTech to keep protection against the virus high.
One month after GlaxoSmithKline outlined plans for the company’s future following a planned split between its pharmaceuticals and consumer health businesses, GSK posted second-quarter 2021 sales of £8.1 billion ($11.2 billion).
Biogen reportedly withdrew a paper that analyzed data from the clinical trials of the Alzheimer’s drug Aduhelm that the company submitted to JAMA after the medical journal requested edits before publication.
Amgen is snapping up privately held Teneobio and the company’s class of biologics dubbed Human Heavy-Chain Antibodies in a deal that could total $2.5 billion.
Bristol Myers Squibb Co. reported second-quarter 2021 earnings that topped Wall Street estimates, as sales of the company’s flagship cancer treatment Opdivo returned to growth after missing estimates in the previous quarter.
AstraZeneca’s Covid-19 vaccine carries a small extra risk of rare blood clots with low platelets after the first dose and no extra risk after the second, a study led and funded by the drugmaker showed on July 28, after worries over side effects.
Americans fully vaccinated against Covid-19 should go back to wearing masks in indoor public places in regions where the coronavirus is spreading rapidly, U.S. health authorities said on July 27.